APA 6th Edition

Perčin, I. (2014). The pathophysiology of rheumatoid arthritis and mechanism of action of subcutaneous tocilizumab. Reumatizam, 61 (2), 167-167. Retrieved from https://hrcak.srce.hr/137960

---

MLA 8th Edition

Perčin, Iva. "The pathophysiology of rheumatoid arthritis and mechanism of action of subcutaneous tocilizumab." Reumatizam, vol. 61, no. 2, 2014, pp. 167-167. https://hrcak.srce.hr/137960. Accessed 7 Jan. 2025.

---

Chicago 17th Edition

Perčin, Iva. "The pathophysiology of rheumatoid arthritis and mechanism of action of subcutaneous tocilizumab." Reumatizam 61, no. 2 (2014): 167-167. https://hrcak.srce.hr/137960

---

Harvard

Perčin, I. (2014). 'The pathophysiology of rheumatoid arthritis and mechanism of action of subcutaneous tocilizumab', Reumatizam, 61(2), pp. 167-167. Available at: https://hrcak.srce.hr/137960 (Accessed 07 January 2025)

---

Vancouver

Perčin I. The pathophysiology of rheumatoid arthritis and mechanism of action of subcutaneous tocilizumab. Reumatizam [Internet]. 2014 [cited 2025 January 07];61(2):167-167. Available from: https://hrcak.srce.hr/137960

---

IEEE

I. Perčin, "The pathophysiology of rheumatoid arthritis and mechanism of action of subcutaneous tocilizumab", Reumatizam, vol.61, no. 2, pp. 167-167, 2014. [Online]. Available: https://hrcak.srce.hr/137960. [Accessed: 07 January 2025]